Only 1 left in stock
LL-37 5mg
$45.00
- LL-37 5mg — cathelicidin-derived 37-residue peptide for laboratory research.
- ≥98% purity (HPLC); identity confirmed by mass spectrometry.
- Lyophilized powder, 5mg per vial. Store at -20°C.
- For laboratory research use only — not for human or veterinary use.
Description
DESCRIPTION
LL-37 5mg is a 37-residue cationic peptide derived from the C-terminal domain of the human cathelicidin precursor protein hCAP18. Its amphipathic α-helical structure positions cationic and hydrophobic residues on opposing faces, a configuration studied for its interaction with anionic microbial membrane components and lipopolysaccharide. In research models, LL-37 is examined for membrane-association behavior, receptor-mediated signaling pathways, and its proposed role as an immunomodulatory mediator within innate-defense systems. This material is provided strictly as a reference compound for in vitro and laboratory investigation.
RESEARCH AREAS
- Cationic peptide–membrane interaction and amphipathic helix formation in model lipid systems
- Lipopolysaccharide binding and neutralization mechanisms in cell-free assays
- Receptor-mediated signaling (e.g., FPR2/formyl peptide receptor) in cultured cell models
- Modulation of innate-immune mediator expression at the transcriptional level
WHAT RESEARCHERS LOOK AT
- Helical content and secondary structure via circular dichroism under varying ionic conditions
- Membrane permeabilization kinetics using dye-leakage and liposome assays
- Binding affinity and stoichiometry against anionic ligands via spectroscopic titration
- Peptide stability and aggregation state across pH and buffer composition
QUICK SPECS
- Form: Lyophilized powder
- Net per vial: 5mg
- Purity: ≥98% (HPLC)
- Identity: Confirmed by mass spectrometry
- Storage: Store at -20°C; protect from light
IDENTITY BASICS
- Type: Cathelicidin-derived antimicrobial peptide (37 residues)
- Sequence/Formula: LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES; C₂₀₅H₃₄₀N₆₀O₅₃
- Molecular weight: ~4493.3 g/mol
- CAS: 154947-66-7
SELECTED RESEARCH
- PubMed: LL-37 the C-terminal peptide of human cathelicidin hCAP18
- PubMed: Structure and membrane interaction of LL-37
- PubMed: LL-37 and FPR2 receptor signaling in immune models
- PubChem: Cathelicidin antimicrobial peptide LL-37 record
⚠️ DISCLAIMER
- For laboratory and in vitro research use only.
- Not for human or veterinary use, consumption, or diagnostic application.
- Not a drug, food, or cosmetic; no therapeutic claims are made or implied.
- Handling restricted to qualified research professionals in an appropriate laboratory setting.







